Key takeaways
- Aging is several loosely coupled processes, not one, which is why no single compound addresses it.
- Telomere shortening is real but oversold as a consumer target.
- Senescent cells accumulate and secrete inflammatory signals; senolytics are the most promising and least proven area.
- Most supplements touch one mechanism at most. Ours is positioned on oxidative resilience and nothing beyond it.
Why "aging" is the wrong singular noun
The influential framing in the field is the hallmarks of aging, a set of distinct, interacting processes first catalogued in 2013 and revised since. The important structural point is that they are distinct. Genomic instability is not the same problem as mitochondrial dysfunction, which is not the same as stem-cell exhaustion.
This is why a product claiming to address aging as such should be treated with suspicion. The defensible form of the claim is always narrower: this input relates to this mechanism, and here is the evidence.
Genomic instability and DNA damage
DNA accumulates damage continuously: from replication errors, radiation, and oxidative processes. Repair machinery is extensive and effective, but neither perfect nor constant across a lifespan.
This is the mechanism the comet assay images directly, and the one the Bacillus F postbiotic is positioned in relation to. Note the careful phrasing: positioned in relation to, not "repairs". Cells repair their own DNA; no supplement does it for them.
Telomeres, senescence and mitochondria
Three of the most discussed hallmarks, with very different evidence quality.
- Telomere attrition. Chromosome ends shorten with each division until replication stops. Real, well-documented, and heavily oversold to consumers. Telomere-lengthening claims deserve scepticism: uncontrolled lengthening is a property of cancer cells, so "longer is better" is not straightforwardly true.
- Cellular senescence. Cells that stop dividing but do not die, secreting inflammatory signals, the senescence-associated secretory phenotype. Accumulation is strongly implicated in tissue aging. Senolytics, which aim to clear these cells, are the most interesting current research direction and among the least established in humans.
- Mitochondrial dysfunction. Output declines and ROS production rises with age. This is where CoQ10, PQQ and NAD+ precursors are positioned. Mechanistically coherent; human outcome data remains thinner than the marketing suggests.
- Loss of proteostasis. Protein folding, chaperoning and disposal degrade over time, allowing misfolded proteins to accumulate. This is the mechanism autophagy inducers such as spermidine address.
How the mechanisms interact
The hallmarks are not independent, which is what makes the field hard. Mitochondrial dysfunction raises ROS production; ROS contribute to genomic instability; genomic instability drives cells into senescence; senescent cells secrete signals that impair mitochondrial function in their neighbours.
It is a set of feedback loops rather than a checklist, which has an important implication for evaluating products: an intervention affecting one node may show effects on markers associated with another, and that makes attribution genuinely difficult even in well-designed studies.
Where cellular health supplements actually sit
Mapping the common shelf onto the mechanisms: NAD+ precursors at mitochondrial function and repair-enzyme capacity. Spermidine at proteostasis via autophagy. Senolytic candidates at senescent-cell burden, with the weakest human evidence and the highest interest. Oxidative-defence preparations, including ours, at the damage-accumulation end.
Note what is absent from that list: nothing on the consumer market credibly addresses stem-cell exhaustion or telomere biology, whatever the label says. And every one of these is a smaller lever than sleep, training and not smoking, which is unglamorous, unprofitable to say, and true.
| Criterion | What is sold against it | State of the human evidence |
|---|---|---|
| Genomic instability | Oxidative-defence preparations, including ours | Preclinical: comet assay on murine cells, ex vivo (2024) |
| Telomere attrition | Telomere-lengthening products | Nothing credible; uncontrolled lengthening is a cancer-cell trait |
| Cellular senescence | Senolytic candidates | Early; the least established in humans |
| Mitochondrial dysfunction | CoQ10, PQQ, NAD+ precursors | Mechanistically coherent; outcome data thin |
| Loss of proteostasis | Spermidine and other autophagy inducers | Observational human data; cell and animal mechanism |
| Stem-cell exhaustion | Nothing on the consumer market | No consumer product addresses it |
Telomere supplement claims versus what the drops are documented for
If you arrived here searching for a telomere supplement, the honest answer is that the Bacillus F drops are not one. Nothing we publish measures telomere length. What we publish is comet-assay imaging of DNA integrity under a hydrogen-peroxide challenge, in murine blood cells, ex vivo, in a 2024 paper (doi 10.1155/2024/4559054). That is the damage-accumulation node on the map above, and only that node.
The strain itself was recovered viable from Siberian permafrost in 2009 after an estimated three million years of dormancy and is documented in patent WO2012060729. The strain page lists the deposit and the publications; the Science page carries the assay panels. If you want to test the preparation against your own markers, the biological-age article sets out the protocol: two baseline readings, one variable, 90 days minimum. Apply the same protocol to any telomere supplement before believing its label.